[Form 4] Life360, Inc. Insider Trading Activity
Charles J. Prober, a director of Life360, Inc. (LIF), reported transactions on 09/15/2025 conducted under a Rule 10b5-1 trading plan. The Form 4 shows an acquisition of 7,930 shares via exercise of stock options at an $11.18 exercise price and a contemporaneous sale of 7,930 shares at $100.24 per share. After the transactions the reporting person’s direct beneficial ownership is reported as 105,456 shares in one line and 111,020 options-related shares in the derivative table; the filing also notes total holdings include 2,036 restricted stock units that convert to common stock upon vesting. The Form 4 states the 10b5-1 plan was adopted on March 14, 2025, and the option vesting schedule is described in the filing.
Charles J. Prober, direttore di Life360, Inc. (LIF), ha riferito operazioni il 15/09/2025 effettuate nell ambito di un piano di trading Rule 10b5-1. Il Form 4 mostra l acquisizione di 7.930 azioni mediante esercizio di opzioni a un prezzo di esercizio di 11,18 USD e una vendita contemporanea di 7.930 azioni a 100,24 USD per azione. Dopo le operazioni la proprietà diretta beneficiaria del soggetto riportante risulta pari a 105.456 azioni in una riga e 111.020 azioni correlate a opzioni nella tavola derivativa; la dichiarazione segnala inoltre che le partecipazioni totali includono 2.036 unità di azioni rimanenti che si trasformano in azioni comuni al vesting. Il Form 4 indica che il piano 10b5-1 è stato adottato il 14 marzo 2025, e lo schema di vesting delle opzioni è descritto nel modulo.
Charles J. Prober, director de Life360, Inc. (LIF), reportó operaciones el 15/09/2025 realizadas bajo un plan de trading Rule 10b5-1. El Form 4 muestra la adquisición de 7.930 acciones mediante ejercicio de opciones a un precio de ejercicio de 11,18 USD y una venta contemporánea de 7.930 acciones a 100,24 USD por acción. Después de las operaciones, la titularidad directa reportada del cedente es de 105.456 acciones en una línea y 111.020 acciones relacionadas con opciones en la tabla derivada; el informe también señala que las participaciones totales incluyen 2.036 unidades de stock restringido que se convierten en acciones comunes al vesting. El Form 4 afirma que el plan 10b5-1 fue adoptado el 14 de marzo de 2025 y que el calendario de vesting de las opciones se describe en el informe.
Charles J. Prober는 Life360, Inc. (LIF)의 이사로서 2025년 9월 15일 Rule 10b5-1 거래계획에 따라 거래를 보고했습니다. Form 4에 따르면 11.18달러의 행사가로 주식 옵션을 행사해 7,930주를 취득했고, 동시에 주당 100.24달러에 7,930주를 매도했습니다. 거래 후 보고자의 직접 유익 소유는 한 줄로 105,456주로 보고되며 파생상품 표에는 옵션 관련 주식 111,020주가 포함됩니다. 보고서는 또한 전체 보유량에 시약 2,036주가 vesting 시 보통주로 전환되는 제한된 주식단위(RESTRICTED STOCK UNITS)를 포함한다고 명시합니다. Form 4는 10b5-1 계획이 2025년 3월 14일에 채택되었고 옵션의 vesting 일정은 신고서에 설명되어 있다고 밝힙니다.
Charles J. Prober, directeur de Life360, Inc. (LIF), a déclaré des transactions le 15/09/2025 réalisées dans le cadre d’un plan de trading Rule 10b5-1. Le Formulaire 4 indique l’acquisition de 7 930 actions par exercice d’options à un prix d’exercice de 11,18 USD et une vente concomitante de 7 930 actions à 100,24 USD par action. Après les opérations, la propriété bénéficiaire directe de la personne reportée est indiquée comme 105 456 actions dans une ligne et 111 020 actions liées à des options dans le tableau dérivé; le document précise également que les participations totales comprennent 2 036 unités d’actions restreintes qui se convertissent en actions ordinaires à l’acquisition. Le Formulaire 4 indique que le plan 10b5-1 a été adopté le 14 mars 2025 et que le calendrier d’acquisition des options est décrit dans le dépôt.
Charles J. Prober, Direktor von Life360, Inc. (LIF), meldete am 15.09.2025 Transaktionen, die im Rahmen eines Rule-10b5-1-Handelsplans durchgeführt wurden. Das Formular 4 zeigt den Erwerb von 7.930 Aktien durch Ausübung von Optionen zu einem Ausübungspreis von 11,18 USD sowie einen gleichzeitigen Verkauf von 7.930 Aktien zu 100,24 USD je Aktie. Nach den Transaktionen wird die direkte wohltätige Eigentümerschaft der meldenden Person in einer Zeile mit 105.456 Aktien und in der Derivate-Tabelle mit 111.020 optionsbezogenen Aktien angegeben; die Einreichung weist außerdem darauf hin, dass Gesamtholdungen 2.036 Restricted Stock Units einschließen, die bei Vesting in Stammaktien umgewandelt werden. Das Formular 4 bestätigt, dass der 10b5-1-Plan am 14. März 2025 angenommen wurde, und der Vesting-Zeitplan der Optionen wird in der Einreichung beschrieben.
شُهر تشارلز ج. بروبر، مدير Life360, Inc. (LIF)، عن معاملات في 15/09/2025 جرت وفق خطة تداول Rule 10b5-1. يظهر النموذج 4 شراء 7,930 سهماً من خلال ممارسة خيارات بسعر تنفيذ 11.18 دولاراً للسهم وباع 7,930 سهماً في الوقت نفسه بسعر 100.24 دولار للسهم. بعد الصفقات، تُذكر الملكية المباشرة المفيدة للمبلغ عنه في سطر واحد وتبلغ 105,456 سهماً وفي الجدول المشتق 111,020 سهماً مرتبطاً بالخيارات؛ كما تشير الإفادة إلى أن الإجماليات تشمل 2,036 وحدة أسهم مقيدة تتحول إلى أسهم عادية عند vesting. كما ينص النموذج 4 على أن خطة 10b5-1 تم اعتمادها في 14 مارس 2025، وأن جدول vesting للخيارات مذكور في الإفادة.
Charles J. Prober，Life360, Inc.（LIF）的董事，报告于2025年9月15日按照Rule 10b5-1交易计划进行交易。 Form 4显示通过行使股票期权以11.18美元的行权价获取7,930股，同时以每股100.24美元的价格出售7,930股。交易结束后，报告人的直接受益所有权在一行中显示为105,456股，衍生表中为111,020股与期权相关的股票；申报还提到总持有量包含2,036个限制性股票单位，在 vesting 时转化为普通股。Form 4指出该10b5-1计划于2025年3月14日通过，且申报中描述了期权的归属时间表。
- Transactions executed under a documented Rule 10b5-1 trading plan adopted March 14, 2025, which supports compliance with insider trading rules
- Exercise price of $11.18 on the reported options is well below the sale price, indicating built-in option value realization
- Director sold 7,930 shares at $100.24, reducing direct beneficial ownership to 105,456 shares as reported
- Filing shows insider monetization of equity, which investors may view as decreased insider-held stock despite compliance
Insights
TL;DR: Routine insider exercise and sale under a pre-established 10b5-1 plan, showing option exercise at a low strike and immediate partial sale at market price.
The filing documents a mechanical exercise of 7,930 options at a stated $11.18 exercise price and a matched sale of 7,930 shares at $100.24, executed pursuant to a Rule 10b5-1 plan adopted March 14, 2025. This indicates the director used a pre-established plan to convert equity compensation into cash while retaining a significant residual stake comprised of common shares, vested options, and 2,036 restricted stock units. The filing is procedural and aligns with disclosed vesting mechanics; it does not present new operational or financial information about the company itself.
TL;DR: Governance appears compliant: transactions were executed under a documented 10b5-1 plan and are disclosed on Form 4.
The report includes the required disclosure that the 10b5-1 plan was adopted when the reporting person was not aware of material nonpublic information, satisfying the affirmative defense statement in the filing. The Form 4 provides vesting details for the option and notes 2,036 restricted stock units included in holdings, which clarifies the nature of the director’s remaining equity exposure. From a governance perspective, the filing is complete and conforms to Section 16 reporting expectations.
Charles J. Prober, direttore di Life360, Inc. (LIF), ha riferito operazioni il 15/09/2025 effettuate nell ambito di un piano di trading Rule 10b5-1. Il Form 4 mostra l acquisizione di 7.930 azioni mediante esercizio di opzioni a un prezzo di esercizio di 11,18 USD e una vendita contemporanea di 7.930 azioni a 100,24 USD per azione. Dopo le operazioni la proprietà diretta beneficiaria del soggetto riportante risulta pari a 105.456 azioni in una riga e 111.020 azioni correlate a opzioni nella tavola derivativa; la dichiarazione segnala inoltre che le partecipazioni totali includono 2.036 unità di azioni rimanenti che si trasformano in azioni comuni al vesting. Il Form 4 indica che il piano 10b5-1 è stato adottato il 14 marzo 2025, e lo schema di vesting delle opzioni è descritto nel modulo.
Charles J. Prober, director de Life360, Inc. (LIF), reportó operaciones el 15/09/2025 realizadas bajo un plan de trading Rule 10b5-1. El Form 4 muestra la adquisición de 7.930 acciones mediante ejercicio de opciones a un precio de ejercicio de 11,18 USD y una venta contemporánea de 7.930 acciones a 100,24 USD por acción. Después de las operaciones, la titularidad directa reportada del cedente es de 105.456 acciones en una línea y 111.020 acciones relacionadas con opciones en la tabla derivada; el informe también señala que las participaciones totales incluyen 2.036 unidades de stock restringido que se convierten en acciones comunes al vesting. El Form 4 afirma que el plan 10b5-1 fue adoptado el 14 de marzo de 2025 y que el calendario de vesting de las opciones se describe en el informe.
Charles J. Prober는 Life360, Inc. (LIF)의 이사로서 2025년 9월 15일 Rule 10b5-1 거래계획에 따라 거래를 보고했습니다. Form 4에 따르면 11.18달러의 행사가로 주식 옵션을 행사해 7,930주를 취득했고, 동시에 주당 100.24달러에 7,930주를 매도했습니다. 거래 후 보고자의 직접 유익 소유는 한 줄로 105,456주로 보고되며 파생상품 표에는 옵션 관련 주식 111,020주가 포함됩니다. 보고서는 또한 전체 보유량에 시약 2,036주가 vesting 시 보통주로 전환되는 제한된 주식단위(RESTRICTED STOCK UNITS)를 포함한다고 명시합니다. Form 4는 10b5-1 계획이 2025년 3월 14일에 채택되었고 옵션의 vesting 일정은 신고서에 설명되어 있다고 밝힙니다.
Charles J. Prober, directeur de Life360, Inc. (LIF), a déclaré des transactions le 15/09/2025 réalisées dans le cadre d’un plan de trading Rule 10b5-1. Le Formulaire 4 indique l’acquisition de 7 930 actions par exercice d’options à un prix d’exercice de 11,18 USD et une vente concomitante de 7 930 actions à 100,24 USD par action. Après les opérations, la propriété bénéficiaire directe de la personne reportée est indiquée comme 105 456 actions dans une ligne et 111 020 actions liées à des options dans le tableau dérivé; le document précise également que les participations totales comprennent 2 036 unités d’actions restreintes qui se convertissent en actions ordinaires à l’acquisition. Le Formulaire 4 indique que le plan 10b5-1 a été adopté le 14 mars 2025 et que le calendrier d’acquisition des options est décrit dans le dépôt.
Charles J. Prober, Direktor von Life360, Inc. (LIF), meldete am 15.09.2025 Transaktionen, die im Rahmen eines Rule-10b5-1-Handelsplans durchgeführt wurden. Das Formular 4 zeigt den Erwerb von 7.930 Aktien durch Ausübung von Optionen zu einem Ausübungspreis von 11,18 USD sowie einen gleichzeitigen Verkauf von 7.930 Aktien zu 100,24 USD je Aktie. Nach den Transaktionen wird die direkte wohltätige Eigentümerschaft der meldenden Person in einer Zeile mit 105.456 Aktien und in der Derivate-Tabelle mit 111.020 optionsbezogenen Aktien angegeben; die Einreichung weist außerdem darauf hin, dass Gesamtholdungen 2.036 Restricted Stock Units einschließen, die bei Vesting in Stammaktien umgewandelt werden. Das Formular 4 bestätigt, dass der 10b5-1-Plan am 14. März 2025 angenommen wurde, und der Vesting-Zeitplan der Optionen wird in der Einreichung beschrieben.
FAQ
What did Life360 director Charles J. Prober report on Form 4 (LIFX)?
Was the transaction part of a 10b5-1 trading plan for Life360 (LIF)?
How many restricted stock units (RSUs) does the reporting person hold?
What is the vesting schedule disclosed for the option?
How many shares does the reporting person beneficially own after the reported transactions?
